SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001044321-07-000210
Filing Date
2007-07-12
Accepted
2007-07-12 11:16:35
Documents
1
Period of Report
2007-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 6145
  Complete submission text file 0001044321-07-000210.txt   8172
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23930 | Film No.: 07975646